Cassava Sciences | PTIE - 営業経費





営業経費 変化する 日付
Abbott USD 9.31B 104M 2026-03
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Cara Therapeutics USD 5.94M 983K 2025-09
Cassava Sciences USD 13.55M 1.69M 2025-12
Eisai JPY 199.9B 16.22B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Geron USD 58.8M 2.31M 2025-12
J&J USD 17.44B 1.53B 2026-03
Merck USD 10.16B 558M 2025-12
Novartis USD 9.8B 61M 2025-12
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12